Trial Summary
What is the purpose of this trial?A behavioral trial aimed at helping patients identify what matters most to them and is part of a larger effort to pivot from disease-oriented care to whole-person care.
Eligibility Criteria
This trial is for individuals experiencing peripheral neuropathy, which often causes numbness, tingling, or pain in the limbs. Participants should be interested in a personalized approach to manage their condition by setting and working towards their own health goals.Inclusion Criteria
I haven't received cancer treatment recently or have been on a stable treatment for 3 months.
Access to smartphone and internet for participating in a technology-based intervention
Provision of signed and dated electronic informed consent form
+8 more
Participant Groups
The intervention being studied is Goal Attainment Scaling (GAS), a method that helps patients set personal health-related goals and track their progress over time. The study focuses on shifting from traditional disease treatment to individualized patient care.
2Treatment groups
Experimental Treatment
Group I: No Goal EncouragementExperimental Treatment1 Intervention
Eligible participants will be identified using electronic health record
Group II: Goal EncouragementExperimental Treatment1 Intervention
Eligible participants will be identified using electronic health record
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
The University of Texas M. D. Anderson Cancer CenterHouston, TX
Loading ...
Who Is Running the Clinical Trial?
M.D. Anderson Cancer CenterLead Sponsor